We present predictions on the total cross sections and on the ratio of the real part to the imaginary part of the elastic amplitude (ρ parameter) for present and future pp andpp colliders, and on total cross sections for γp → hadrons at cosmic-ray energies and for γγ → hadrons up to √ s = 1TeV. These predictions are based on an extensive study of possible analytic parametrisations invoking the biggest hadronic dataset available at t = 0. The uncertainties on total cross sections, including the systematic errors due to contradictory data points from FNAL, can reach 1.9%at RHIC, 3.1% at the Tevatron, and 4.8% at the LHC, whereas those on the ρ parameter are respectively 5.4%, 5.2%, and 5.4%.
The Donnachie-Landshoff fit of total cross sections has now become a standard reference for models of total, elastic and diffractive cross-sections. Adopting their philosophy that simple-pole exchanges should account for all data to present energies, we assess the uncertainties on their fits. Our best estimate for the pomeron intercept is 1.096 +0.012 −0.009 , but several models have a good χ 2 for intercepts in the range [1.07,1.11].
Resveratrol (3,5,4'-trihydroxystilbene), a naturally occurring phytoalexin present in grapes and other foods, has been reported to possess chemopreventive effects as revealed by its striking inhibition of diverse cellular events associated with tumor initiation, promotion and progression. In our present study, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), when treated with the cultured human mammary epithelial (MCF-10A) cells, induced the expression of cytochrome P450 1A1 (CYP1A1) and 1B1 (CYP1B1) that are responsible for the oxidation of 17beta-estradiol to produce catechol estrogens. Resveratrol strongly inhibited the TCDD-induced aryl hydrocarbon receptor (AhR) DNA binding activity, the expression of CYP1A1 and CYP1B1 and their catalytic activities in MCF-10A cells. It also reduced the formation of 2-hydroxyestradiol and 4-hydroxyestradiol from 17beta-estradiol by recombinant human CYP1A1 and CYP1B1, respectively. Furthermore, resveratrol significantly attenuated the intracellular reactive oxygen species (ROS) formation and oxidative DNA damage as well as the cytotoxicity induced by the catechol estrogens. Our data suggest that CYP1A1- and CYP1B1-catalyzed catechol estrogen formation might play a key role in TCDD-induced oxidative damage, and resveratrol can act as a potential chemopreventive against dioxin-induced human mammary carcinogenesis by blocking the metabolic formation of the catechol estrogens and scavenging the ROS generated during their redox cycling.
We present a formalism for the description of oscillations in matter of solar, atmospheric and long-baseline neutrinos in the two schemes of four-neutrino mixing that are allowed by the results of all existing neutrino oscillation experiments.
We reanalyze high energy QCD scattering regimes from scattering in cut-off AdS via gravity-gauge dualities (a la PolchinskiStrassler). We look at 't Hooft scattering, Regge behaviour and black hole creation in AdS. Black hole creation in the gravity dual is analyzed via gravitational shockwave collisions. We prove the saturation of the QCD Froissart unitarity bound, corresponding to the creation of black holes of AdS size, as suggested by Giddings.
The recent results of rising total cross sections for rr'p , K ' p , and pp scattering are analyzed by two simple analytic models for high-energy forward scattering which are derived from analyticity, crossing symmetry, and the unitarity constraints of the rigorous results. The numerical fit to the data for p , 2 10 GeV/c does not rule out the possibility that the crossing-odd amplitude may not be negligible at high energies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.